Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Veber

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Endocrinology and Metabolism Clinics of North America|March 1, 1987
Chemical synthesis and structure-activity relations for ANF analoguesR F Nutt, D F Veber
Current Opinion in Drug Discovery & Development|August 4, 2009
The therapeutic potential of advances in cysteine protease inhibitor designD F Veber, S K Thompson
Biochemical and Biophysical Research Communications|January 29, 1986
Computer-aided, systematic search of peptide conformations constrained by NMR dataG M Smith, D F Veber
Current Opinion in Chemical Biology|August 1, 1997
The new partnership of genomics and chemistry for accelerated drug developmentD F Veber, F H Drake, M Gowen
International Journal of Peptide and Protein Research|November 1, 1980
Lactam restriction of peptide conformation in cyclic hexapeptides which alter rumen fermentationR M Freidinger, D F Veber, R Hirschmann, et al.
Organic Letters|August 17, 2001
Aspartic protease inhibitors: expedient synthesis of 2-substituted statinesJ M Travins, M G Bursavich, D F Veber, et al.
International Journal of Peptide and Protein Research|January 1, 1983
Somatostatin analogs which define the role of the lysine-9 amino groupR F Nutt, D F Veber, P E Curley, et al.
Klinische Wochenschrift|January 1, 1986
Somatostatin analogs with improved oral bioavailabilityR F Nutt, C D Colton, D F Veber, et al.
Science (New York, N.Y.)|November 7, 1980
Bioactive conformation of luteinizing hormone-releasing hormone: evidence from a conformationally constrained analogR M Freidinger, D F Veber, D S Perlow, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1978
Subcutaneous administration of somatostatin analogs as a major factor in the enhancement of the duration of actionM L Torchiana, P G Cook, S R Wiese, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Endocrinology and Metabolism Clinics of North America|March 1, 1987
Chemical synthesis and structure-activity relations for ANF analoguesR F Nutt, D F Veber
Current Opinion in Drug Discovery & Development|August 4, 2009
The therapeutic potential of advances in cysteine protease inhibitor designD F Veber, S K Thompson
Biochemical and Biophysical Research Communications|January 29, 1986
Computer-aided, systematic search of peptide conformations constrained by NMR dataG M Smith, D F Veber
Current Opinion in Chemical Biology|August 1, 1997
The new partnership of genomics and chemistry for accelerated drug developmentD F Veber, F H Drake, M Gowen
International Journal of Peptide and Protein Research|November 1, 1980
Lactam restriction of peptide conformation in cyclic hexapeptides which alter rumen fermentationR M Freidinger, D F Veber, R Hirschmann, et al.
Organic Letters|August 17, 2001
Aspartic protease inhibitors: expedient synthesis of 2-substituted statinesJ M Travins, M G Bursavich, D F Veber, et al.
International Journal of Peptide and Protein Research|January 1, 1983
Somatostatin analogs which define the role of the lysine-9 amino groupR F Nutt, D F Veber, P E Curley, et al.
Klinische Wochenschrift|January 1, 1986
Somatostatin analogs with improved oral bioavailabilityR F Nutt, C D Colton, D F Veber, et al.
Science (New York, N.Y.)|November 7, 1980
Bioactive conformation of luteinizing hormone-releasing hormone: evidence from a conformationally constrained analogR M Freidinger, D F Veber, D S Perlow, et al.
Archives Internationales De Pharmacodynamie Et De Therapie|September 1, 1978
Subcutaneous administration of somatostatin analogs as a major factor in the enhancement of the duration of actionM L Torchiana, P G Cook, S R Wiese, et al.
Pageof 7